Simplex Trading
SRNE

Simplex Trading’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Simplex Trading’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-147,289
Closed -$195K – 10947
2022
Q3 		$231K Sell
147,289
-100,268
-41% -$227K ﹤0.01% 4423
2022
Q2 		$497K Buy
247,557
+168,853
+215% +$292K ﹤0.01% 3456
2022
Q1 		$183K Buy
+78,704
New +$245K ﹤0.01% 5291
2021
Q2 		– Sell
-1,200
Closed -$9.56K – 10942
2021
Q1 		$0 Hold
1,200
– – ﹤0.01% 10400
2020
Q4 		$8K Sell
1,200
-1,020
-46% -$8.19K ﹤0.01% 7557
2020
Q3 		$24K Buy
2,220
+470
+27% +$4.3K ﹤0.01% 6261
2020
Q2 		$10K Buy
+1,750
New +$6.7K ﹤0.01% 6678
2018
Q1 		– Sell
-15,107
Closed -$107K – 7109
2017
Q4 		$57K Buy
+15,107
New +$39.3K ﹤0.01% 2325
2017
Q2 		– Sell
-2,037
Closed -$8K – 7018
2017
Q1 		$8K Sell
2,037
-11,979
-85% -$60.1K ﹤0.01% 4220
2016
Q4 		$68K Buy
+14,016
New +$84.2K ﹤0.01% 1862
2015
Q2 		– Sell
-7,335
Closed -$94.2K – 6044
2015
Q1 		$84K Buy
+7,335
New +$84.9K 0.01% 1205

Other funds holding SRNE

SW
SlateStone Wealth Jupiter, Florida $1.31B AUM 26.51% 1-Year Est. Return
KA
KLCM Advisors Milwaukee, Wisconsin $1.27B AUM 31.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $403M AUM 22.57% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.68B AUM
CFGS
Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return

Simplex Trading's SRNE Position: Q4 2022 in Review

Simplex Trading sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2022, closing a stake of 147,289 shares — an estimated $195K sold.

Simplex Trading first reported a position in SRNE in Q1 2015 and held it in 11 quarters. The position peaked at $497K in Q2 2022. 221 funds tracked by Wall St. Rank hold SRNE as of Q4 2022.

  • Simplex Trading reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 147,289 Sorrento Therapeutics, Inc. shares in Q4 2022, an estimated $195K.
  • Simplex Trading first reported a position in Sorrento Therapeutics, Inc. in Q1 2015 and held it in 11 quarters.
  • Simplex Trading's Sorrento Therapeutics, Inc. position peaked at $497K in Q2 2022.
  • 221 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.